Expert survey on management of prostate cancer in India

Abstract

To gain insights on the diverse practice patterns and treatment pathways for prostate cancer (PC) in India, the Urological Cancer Foundation convened the first Indian survey to discuss all aspects of PC, with the objective of guiding clinicians on optimizing management in PC. A modified Delphi method was used, wherein a multidisciplinary panel of oncologists treating PC across India developed a questionnaire related to screening, diagnosis and management of early, locally advanced and metastatic PC and participated in a web–based survey (WBS) (n = 62). An expert committee meeting (CM) (n = 48, subset from WBS) reviewed the ambiguous questions for better comprehension and reanalyzed the evidence to establish a revote for specific questions. The threshold for strong agreement and agreement was ≥90% and ≥75% agreement, respectively. Sixty-two questions were answered in the WBS; in the CM 31 questions were revoted and 4 questions were added. The panelists selected answers based on their best opinion and closest to their practice strategy, not considering financial constraints and access challenges. Of the 66 questions, strong agreement was reached for 17 questions and agreement was achieved for 22 questions. There were heterogeneous responses for 27 questions indicative of variegated management approaches. This is one of the first Indian survey, documenting the diverse clinical practice patterns in the management of PC in India. It aims to provide guidance in the face of technological advances, resource constraints and sparse high-level evidence..

A Glimpse into the Epidemiology of Geriatric Cancers in India: Report from the Indian Population Based Cancer Registries

“…Though prostate cancer is a disease of the OAs, [34] lung cancer seems to have a higher incidence than prostate cancer in Indian OAs. However, there is no robust screening program for prostate cancers in India, as compared to globally, hence the detection rates may be lower [35,36].…”

Concomitant Bilateral Inferior Gluteal Lymph Node Involvement in Metastatic Prostate Adenocarcinoma Detected on 68Gallium-Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography

“…Prostate cancer is the sixth leading cause of cancer death among men worldwide and the fifth highest incidence rate among males in India in 2016. 4 5 In high-risk prostate cancer, 68 Ga-PSMA-11 PET/CT is known to be a useful method for the detection of metastases. 6 Associated with the rise of prostate cancer, use of PSMA-PET/CT has been indicated for staging in high-risk prostate cancer, response assessment after therapeutic interventions in correlation with serum PSA levels, and evaluating biochemical recurrence and prior to planning patients for 177 Lu-PSMA-617 therapy.…”

Descriptive epidemiology of prostate cancer in India, 2012–2019: Insights from the National Cancer Registry Programme

“…[ 2 30 31 32 33 ] There is a common consensus that opportunistic and executive health checkup screenings are viable options to be considered for a country like India for downstaging the disease. [ 34 35 ]…”